TNF PRODUCTION AND HYPERTROPHIC SCARRING

被引:46
作者
CASTAGNOLI, C
STELLA, M
BERTHOD, C
MAGLIACANI, G
RICHIARDI, PM
机构
[1] CNR,CTR IMMUNOGENET & HISTOCOMPATIBIL,TURIN,ITALY
[2] TRAUMATOL CTR,DEPT PLAST SURG,TURIN,ITALY
[3] TRAUMATOL CTR,BURN UNIT,TURIN,ITALY
关键词
D O I
10.1006/cimm.1993.1047
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The percentage of TNF α- and β-positive cells was analyzed in hypertrophic scar (N = 13), normotrophic scar (N = 7), and normal skin (N = 6) biopsies using monoclonal antibodies and immunoperoxidase staining of cryostat tissue sections. Samples were first characterized for infiltrating cells. In hypertrophic samples there was a significant increase in activated infiltrating cells, capable of producing TNE β and IL-1β. In contrast, the percentage of TNF α-positive cells was significantly lower than that detected in normotrophic scars. In fact, in hypertrophic scar samples a positive staining with anti-TNF α mAb was restricted to 8% of tissue-infiltrating cells compared to 35.4% of the cells present in normotrophic scars; 12% of infiltrating cells were stained in normal skin sections. These results suggest that TNF α may be important for normal wound healing and that hypertrophic scarring might be partially a consequence of a low amount of TNF α.
引用
收藏
页码:51 / 63
页数:13
相关论文
共 21 条
[1]   FIBROBLAST GROWTH-STIMULATORY ACTIVITY RELEASED FROM HUMAN-MONOCYTES - THE CONTRIBUTION OF TUMOR-NECROSIS-FACTOR [J].
AUSTGULEN, R ;
ESPEVIK, T ;
NISSENMEYER, J .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1987, 26 (06) :621-629
[2]   ASSOCIATION BETWEEN HLA-DR2 AND PRODUCTION OF TUMOR NECROSIS FACTOR-ALPHA AND INTERLEUKIN-1 BY MONONUCLEAR-CELLS ACTIVATED BY LIPOPOLYSACCHARIDE [J].
BENDTZEN, K ;
MORLING, N ;
FOMSGAARD, A ;
SVENSON, M ;
JAKOBSEN, B ;
ODUM, N ;
SVEJGAARD, A .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1988, 28 (05) :599-606
[3]  
CASTAGNOLI C, 1990, CLIN EXP IMMUNOL, V82, P350
[4]   THE HLA-DR-BETA-16 ALLOGENOTYPE CONSTITUTES A RISK FACTOR FOR HYPERTROPHIC SCARRING [J].
CASTAGNOLI, C ;
PERUCCIO, D ;
STELLA, M ;
MAGLIACANI, G ;
MAZZOLA, G ;
AMOROSO, A ;
RICHIARDI, P .
HUMAN IMMUNOLOGY, 1990, 29 (03) :229-232
[5]  
CASTAGNOLI C, 1989, RIV ITAL CHIR PLASTI, V21, P199
[6]  
CREPALDI T, 1985, J IMMUNOGENET, V12, P301
[7]   INDEPENDENT REGULATION OF TUMOR-NECROSIS-FACTOR AND LYMPHOTOXIN PRODUCTION BY HUMAN PERIPHERAL-BLOOD LYMPHOCYTES [J].
CUTURI, MC ;
MURPHY, M ;
COSTAGIOMI, MP ;
WEINMANN, R ;
PERUSSIA, B ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (06) :1581-1594
[8]   CACHECTIN TUMOR NECROSIS FACTOR STIMULATES COLLAGENASE AND PROSTAGLANDIN-E2 PRODUCTION BY HUMAN SYNOVIAL-CELLS AND DERMAL FIBROBLASTS [J].
DAYER, JM ;
BEUTLER, B ;
CERAMI, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (06) :2163-2168
[9]  
DUNCAN MR, 1989, J INVEST DERMATOL, V92, P99
[10]   REGULATION OF HUMAN-LUNG FIBROBLAST GLYCOSAMINOGLYCAN PRODUCTION BY RECOMBINANT INTERFERONS, TUMOR NECROSIS FACTOR, AND LYMPHOTOXIN [J].
ELIAS, JA ;
KROL, RC ;
FREUNDLICH, B ;
SAMPSON, PM .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (02) :325-333